These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 25646773)

  • 1. Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt.
    Kenerson HL; Subramanian S; McIntyre R; Kazami M; Yeung RS
    PLoS One; 2015; 10(2):e0117000. PubMed ID: 25646773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation.
    Kenerson HL; Yeh MM; Yeung RS
    PLoS One; 2011 Mar; 6(3):e18075. PubMed ID: 21479224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase.
    Copps KD; Hançer NJ; Qiu W; White MF
    J Biol Chem; 2016 Apr; 291(16):8602-17. PubMed ID: 26846849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways.
    Yecies JL; Zhang HH; Menon S; Liu S; Yecies D; Lipovsky AI; Gorgun C; Kwiatkowski DJ; Hotamisligil GS; Lee CH; Manning BD
    Cell Metab; 2011 Jul; 14(1):21-32. PubMed ID: 21723501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fisetin regulates obesity by targeting mTORC1 signaling.
    Jung CH; Kim H; Ahn J; Jeon TI; Lee DH; Ha TY
    J Nutr Biochem; 2013 Aug; 24(8):1547-54. PubMed ID: 23517912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of S6K1 increases glucose metabolism and Akt signalling in vitro and in diet-induced obese mice.
    Shum M; Bellmann K; St-Pierre P; Marette A
    Diabetologia; 2016 Mar; 59(3):592-603. PubMed ID: 26733005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism.
    Guridi M; Kupr B; Romanino K; Lin S; Falcetta D; Tintignac L; Rüegg MA
    Skelet Muscle; 2016; 6():13. PubMed ID: 27004103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt and mTORC1 have different roles during liver tumorigenesis in mice.
    Kenerson HL; Yeh MM; Kazami M; Jiang X; Riehle KJ; McIntyre RL; Park JO; Kwon S; Campbell JS; Yeung RS
    Gastroenterology; 2013 May; 144(5):1055-65. PubMed ID: 23376645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability.
    Pajvani UB; Qiang L; Kangsamaksin T; Kitajewski J; Ginsberg HN; Accili D
    Nat Med; 2013 Aug; 19(8):1054-60. PubMed ID: 23832089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive adipocyte mTORC1 activation enhances mitochondrial activity and reduces visceral adiposity in mice.
    Magdalon J; Chimin P; Belchior T; Neves RX; Vieira-Lara MA; Andrade ML; Farias TS; Bolsoni-Lopes A; Paschoal VA; Yamashita AS; Kowaltowski AJ; Festuccia WT
    Biochim Biophys Acta; 2016 May; 1861(5):430-8. PubMed ID: 26923434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.
    Gong Q; Hu Z; Zhang F; Cui A; Chen X; Jiang H; Gao J; Chen X; Han Y; Liang Q; Ye D; Shi L; Chin YE; Wang Y; Xiao H; Guo F; Liu Y; Zang M; Xu A; Li Y
    Hepatology; 2016 Aug; 64(2):425-38. PubMed ID: 26926384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSC1/TSC2 inactivation inhibits AKT through mTORC1-dependent up-regulation of STAT3-PTEN cascade.
    Zha X; Hu Z; He S; Wang F; Shen H; Zhang H
    Cancer Lett; 2011 Dec; 313(2):211-7. PubMed ID: 22055460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSC but not PTEN loss in starving cones of retinitis pigmentosa mice leads to an autophagy defect and mTORC1 dissociation from the lysosome.
    Venkatesh A; Ma S; Punzo C
    Cell Death Dis; 2016 Jun; 7(6):e2279. PubMed ID: 27362797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
    Pan Q; Qin T; Gao Y; Li S; Li D; Peng M; Zhai H; Xu G
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):525-534. PubMed ID: 30562559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
    Veilleux A; Houde VP; Bellmann K; Marette A
    Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21.
    Cornu M; Oppliger W; Albert V; Robitaille AM; Trapani F; Quagliata L; Fuhrer T; Sauer U; Terracciano L; Hall MN
    Proc Natl Acad Sci U S A; 2014 Aug; 111(32):11592-9. PubMed ID: 25082895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling.
    Chen Y; Wei H; Liu F; Guan JL
    J Biol Chem; 2014 Jan; 289(2):1164-73. PubMed ID: 24275666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway.
    Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z
    Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2.
    Huang J; Dibble CC; Matsuzaki M; Manning BD
    Mol Cell Biol; 2008 Jun; 28(12):4104-15. PubMed ID: 18411301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis.
    Uehara K; Sostre-Colón J; Gavin M; Santoleri D; Leonard KA; Jacobs RL; Titchenell PM
    Cell Mol Gastroenterol Hepatol; 2022; 13(6):1625-1647. PubMed ID: 35240344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.